Patent · US Active

Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue

US7939078B2 · kind B2 · utility

0Cited by
6References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 2005
Grant dateMay 10, 2011
Priority date—
Expiry dateMar 18, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/0661
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Co-administration of an effective amount of autoantigen and UV light to mucosal associated lymphatic tissue (MALT) in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.